Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-May-23 4:54 PM View:  | Grais Linda S Director | Corvus Pharmaceuticals, Inc. (CRVS) | 15-May-23 | Purchase | 10,000 | $2.45 | $24,500.00 | 100% 0 to 10.0K | |
| 20-Dec-22 6:22 PM View: | Jones William Benton See Remarks | Corvus Pharmaceuticals, Inc. (CRVS) | 20-Dec-22 | Private Purchase | 20,000 | $0.79 | $15,800.00 | 18% 113.77K to 133.77K | |
| 15-Dec-22 4:32 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 14-Dec-22 | Purchase | 10,000 | $0.78 | $7,812.00 | < 1% 1.48M to 1.49M | |
| 15-Dec-22 4:33 PM View: | Lea Leiv Chief Financial Officer | Corvus Pharmaceuticals, Inc. (CRVS) | 14-Dec-22 | Purchase | 4,000 | $0.84 | $3,364.00 | 1% 278.44K to 282.44K | |
| 15-Dec-22 4:33 PM View: | Lea Leiv Chief Financial Officer | Corvus Pharmaceuticals, Inc. (CRVS) | 13-Dec-22 | Private Purchase | 30,000 | $0.74 | $22,275.00 | 12% 248.44K to 278.44K | |
| 15-Dec-22 4:32 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 13-Dec-22 | Private Purchase | 50,000 | $0.74 | $37,015.00 | 3% 1.43M to 1.48M | |
| 28-Sep-22 5:45 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 28-Sep-22 | Private Purchase | 25,000 | $0.76 | $19,070.00 | 2% 1.41M to 1.43M | |
| 20-Sep-22 6:58 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 20-Sep-22 | Private Purchase | 20,000 | $0.81 | $16,253.20 | 1% 1.39M to 1.41M | |
| 28-Jun-22 7:15 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 27-Jun-22 | Purchase | 5,000 | $1.00 | $4,984.50 | < 1% 1.38M to 1.39M | |
| 28-Jun-22 7:15 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 24-Jun-22 | Private Purchase | 5,000 | $1.03 | $5,150.00 | < 1% 1.38M to 1.38M | |
| 06-Jun-22 6:43 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 06-Jun-22 | Purchase | 890 | $1.01 | $898.90 | < 1% 1.37M to 1.38M | |
| 06-Jun-22 6:43 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 02-Jun-22 | Private Purchase | 5,000 | $0.98 | $4,898.30 | < 1% 1.37M to 1.37M | |
| 01-Apr-22 4:18 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 31-Mar-22 | Private Purchase | 15,000 | $1.64 | $24,534.00 | 1% 1.35M to 1.37M | |
| 17-Mar-22 7:10 PM View: | Lea Leiv Chief Financial Officer | Corvus Pharmaceuticals, Inc. (CRVS) | 17-Mar-22 | Purchase | 13,878 | $1.65 | $22,898.70 | 6% 234.57K to 248.44K | |
| 17-Mar-22 7:09 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 17-Mar-22 | Purchase | 5,000 | $1.59 | $7,950.00 | < 1% 1.35M to 1.35M | |
| 17-Mar-22 7:10 PM View: | Lea Leiv Chief Financial Officer | Corvus Pharmaceuticals, Inc. (CRVS) | 16-Mar-22 | Private Purchase | 35,160 | $1.54 | $54,146.40 | 18% 199.41K to 234.57K | |
| 17-Mar-22 7:09 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 15-Mar-22 | Private Purchase | 25,000 | $1.47 | $36,650.00 | 2% 1.32M to 1.35M | |
| 01-Oct-21 7:39 PM View: | Ecor1 Capital, LLC 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 01-Oct-21 | Market Sale | 2,000,000 | $4.96 | $9,928,800.00 | (96%) 2.08M to 81.08K | 3% |
| 01-Oct-21 7:39 PM View: | Ecor1 Capital, LLC 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 30-Sep-21 | Market Sale | 3,000,000 | $5.04 | $15,131,100.00 | (59%) 5.08M to 2.08M | 4% |
| 22-Sep-21 10:00 PM View: | Orbimed Advisors LLC Director 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 20-Sep-21 | Market Sale Duplicate | 1,109,640 | $6.09 | $6,757,730.00 | (14%) 8.05M to 6.94M | (12%) |
| 22-Sep-21 10:00 PM View: | Thompson Peter A Director 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 20-Sep-21 | Market Sale | 1,109,640 | $6.09 | $6,757,730.00 | (14%) 8.05M to 6.94M | (12%) |
| 23-Aug-21 9:01 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 20-Aug-21 | Market Purchase | 10,000 | $1.93 | $19,254.00 | < 1% 1.31M to 1.32M | (< 1%) |
| 05-May-21 5:01 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 04-May-21 | Market Purchase | 35,714 | $2.80 | $99,999.20 | 3% 1.28M to 1.31M | 1% |
| 19-Feb-21 4:47 PM View: | Thompson Peter A Director 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 17-Feb-21 | Market Purchase | 1,285,710 | $3.50 | $4,500,000.00 | 19% 6.77M to 8.05M | 7% |
| 17-Feb-21 4:44 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 17-Feb-21 | Market Purchase | 100,000 | $3.50 | $350,000.00 | 8% 1.18M to 1.28M | 2% |
| 19-Feb-21 4:52 PM View: | Orbimed Advisors LLC Director 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 17-Feb-21 | Market Purchase Duplicate | 1,285,710 | $3.50 | $4,500,000.00 | 19% 6.77M to 8.05M | 7% |
| 09-Jul-20 4:35 PM View: | Novo A/s 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 08-Jul-20 | Market Sale | 741,440 | $5.37 | $3,985,170.00 | (35%) 2.13M to 1.39M | 27% |
| 09-Jul-20 4:35 PM View: | Novo A/s 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 07-Jul-20 | Market Sale | 796,622 | $5.25 | $4,183,380.00 | (27%) 2.93M to 2.13M | 25% |
| 14-Nov-19 4:14 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 13-Nov-19 | Market Purchase | 14,736 | $3.00 | $44,240.40 | 1% 1.16M to 1.18M | 32% |
| 14-Nov-19 4:14 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 12-Nov-19 | Market Purchase | 272 | $2.90 | $788.80 | < 1% 1.16M to 1.16M | 36% |
| 08-Aug-19 4:07 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 07-Aug-19 | Market Purchase | 2,500 | $3.54 | $8,850.00 | < 1% 1.16M to 1.16M | 12% |
| 08-Aug-19 4:07 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 06-Aug-19 | Market Purchase | 5,000 | $3.58 | $17,875.00 | < 1% 1.16M to 1.16M | 11% |
| 08-Aug-19 4:59 PM View: | Orbimed Advisors LLC Director 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 06-Aug-19 | Market Purchase | 142,656 | $3.51 | $500,723.00 | 2% 6.62M to 6.77M | 13% |
| 08-Aug-19 5:00 PM View: | Thompson Peter A Director 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 06-Aug-19 | Market Purchase Duplicate | 142,656 | $3.51 | $500,723.00 | 2% 6.62M to 6.77M | 13% |
| 25-Jul-19 7:21 PM View: | Novo A/s 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 25-Jul-19 | Sale | 1,400,000 | $4.00 | $5,600,000.00 | (32%) 4.33M to 2.93M | |
| 25-Jul-19 7:21 PM View: | Novo A/s 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 24-Jul-19 | Market Sale | 53,240 | $5.01 | $266,711.00 | (1%) 4.38M to 4.33M | 21% |
| 25-Jul-19 7:21 PM View: | Novo A/s 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 23-Jul-19 | Market Sale | 39,716 | $5.32 | $211,134.00 | (< 1%) 4.42M to 4.38M | 26% |
| 01-Jul-19 6:15 PM View: | Orbimed Advisors LLC Director 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 01-Jul-19 | Market Purchase | 59,243 | $3.91 | $231,640.00 | < 1% 6.57M to 6.62M | 1% |
| 01-Jul-19 6:16 PM View: | Thompson Peter A Director 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 01-Jul-19 | Market Purchase Duplicate | 59,243 | $3.91 | $231,640.00 | < 1% 6.57M to 6.62M | 1% |
| 01-Jul-19 6:16 PM View: | Thompson Peter A Director 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 28-Jun-19 | Market Purchase Duplicate | 565,178 | $3.72 | $2,102,460.00 | 9% 6.0M to 6.57M | 6% |
| 01-Jul-19 6:15 PM View: | Orbimed Advisors LLC Director 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 28-Jun-19 | Market Purchase | 565,178 | $3.72 | $2,102,460.00 | 9% 6.0M to 6.57M | 6% |
| 01-Jul-19 6:15 PM View: | Orbimed Advisors LLC Director 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 27-Jun-19 | Market Purchase | 32,923 | $3.34 | $109,963.00 | < 1% 5.97M to 6.0M | 18% |
| 01-Jul-19 6:16 PM View: | Thompson Peter A Director 10% Owner | Corvus Pharmaceuticals, Inc. (CRVS) | 27-Jun-19 | Market Purchase Duplicate | 32,923 | $3.34 | $109,963.00 | < 1% 5.97M to 6.0M | 18% |
| 17-Jun-19 4:08 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 14-Jun-19 | Market Purchase | 11,657 | $3.40 | $39,666.40 | 1% 1.14M to 1.16M | 16% |
| 17-Jun-19 4:08 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 13-Jun-19 | Market Purchase | 343 | $3.52 | $1,207.36 | < 1% 1.14M to 1.14M | 12% |
| 11-Jun-19 4:55 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 11-Jun-19 | Market Purchase | 6,000 | $3.67 | $22,020.00 | < 1% 1.14M to 1.14M | 8% |
| 10-Jun-19 4:12 PM View: | Lea Leiv Chief Financial Officer | Corvus Pharmaceuticals, Inc. (CRVS) | 07-Jun-19 | Market Purchase | 10,000 | $3.38 | $33,800.00 | 5% 189.41K to 199.41K | 17% |
| 11-Jun-19 4:55 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 07-Jun-19 | Market Purchase | 9,212 | $3.37 | $31,018.60 | < 1% 1.13M to 1.14M | 18% |
| 10-Jun-19 4:12 PM View: | Lea Leiv Chief Financial Officer | Corvus Pharmaceuticals, Inc. (CRVS) | 06-Jun-19 | Market Purchase | 15,500 | $3.56 | $55,180.00 | 9% 173.91K to 189.41K | 11% |
| 31-Dec-18 4:16 PM View: | Miller Richard A Md President and CEO Director | Corvus Pharmaceuticals, Inc. (CRVS) | 27-Dec-18 | Market Purchase | 20,000 | $3.29 | $65,884.00 | 2% 1.11M to 1.13M | 20% |
